Discovery & development of breakthrough therapies for COVID-19 patients and severe viral diseases
Joined August 2020
- Tweets 28
- Following 8
- Followers 80
- Likes 0
11 Photos and videos
5 Jun 2024
Today, we are excited to announce positive initial data from the Ph2 study evaluating bemnifosbuvir, our oral nucleotide polymerase inhibitor in combination with ruzasvir, an oral NS5A inhibitor, for the treatment of #HepC at #EASLCongress 2024.
ir.ateapharma.com/news-relea…
1
167
27 Mar 2024
Today, we are pleased to announce enrollment completion in the global Ph3 SUNRISE-3 trial evaluating bemnifosbuvir, our oral nucleotide antiviral, for the treatment of #COVID19. ir.ateapharma.com/news-relea…
2
151
22 Jun 2023
Former Surgeon General @JeromeAdamsMD explains how we can protect vulnerable seniors and immunocompromised patients by prioritizing new #COVID19 oral antiviral treatments. Read more @statnews: statnews.com/2023/06/22/covi…
126
6 Jun 2023
Collectively, we can – and must – continue to raise awareness, education and funding to expand #COVID19 treatment options for those most vulnerable and ensure pandemic preparedness. Read more @Politico: bit.ly/3OO7OVD
122
10 Feb 2022
#Atea Pharmaceuticals appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development. Pharmaceutical research leader brings more than 25 years of drug discovery and development experience from Merck.
ir.ateapharma.com/news-relea…
11 Nov 2021
#Atea 3Q21 update for #AT527 for #COVID19: planned amendment to Ph3 MORNINGSKY protocol, exploratory analyses of infectious virus from Ph2 MOONSONG trial and new in vitro results demonstrating potent activity against COVID #variants, including Delta.
ir.ateapharma.com/news-relea…
24 Aug 2021
#Atea Pharmaceuticals announces publication of data highlighting AT-752’s potent in vitro and in vivo activity against #dengue and other #flaviviruses in Antimicrobial Agents and Chemotherapy #AAC #AT752
ir.ateapharma.com/news-relea…
5 Aug 2021
Please join us for a clinical, corporate and financial update on our second quarter 2021 earnings conference call, taking place on August 12 at 4:30pm ET.
#COVID #antiviral #pandemic
ir.ateapharma.com/news-relea…
1
30 Jun 2021
Positive interim results from global Ph 2 trial for AT-527 indicate rapid, sustained antiviral activity against SARS-CoV-2 in hospitalized patients with COVID-19. Atea and Roche are jointly developing AT-527, an oral direct-acting antiviral agent #pandemic
ir.ateapharma.com/news-relea…
3
3
We are thrilled about working with our partner @AteaPharmaceuticals and the potential impact this innovation might have in the fight against the #pandemic! The @NYtimes shines a light on this and other possible treatments to end #covid19 👉 nyti.ms/2TLCkEZ
7
27
16 Jun 2021
#Atea Milestone: We achieved a development milestone for AT-527 and expect to receive a $50M payment from Roche. Realization of this milestone brings us one step closer to providing an oral, easily administered #antiviral to fight this #COVID-19 #pandemic. ir.ateapharma.com/news-relea…
1
1
1
15 Jun 2021
Our Senior Management Team expands: we appointed Claudio Avila, MB, BS, Ph.D., as SVP of Medical Affairs. Claudio joins from Gilead where he was Executive Director of U.S. Medical Strategy & Medical Affairs for COVID-19. Welcome to the team, Claudio!
ir.ateapharma.com/news-relea…
29 Apr 2021
#Atea milestone: dosed #firstpatient PH 3 #MORNINGSKY - a global multicenter #AT527 trial in mild/moderate COVID-19 pts. MORNINGSKY to enroll 1,400 non-hospitalized adults/adolescents – our goal is to provide an oral antiviral to fight global #pandemic.
ir.ateapharma.com/news-relea…
1
3
10 Apr 2021
.@statnews reported on Atea’s oral antiviral drug candidate #AT527, a potential treatment for #COVID19, in their recent article "Scientists work toward an elusive dream: a simple pill to treat Covid19"
statnews.com/2021/04/09/scie…
2
1
ateapharma retweeted
9 Mar 2021
A pill for #covid19 you could take for 5 days upon diagnosis and be done? A number of antiviral drugs are in development for #covid19. We talked with Dr Fauci and @cispt2 about the hope for these drugs and how they're different:
9 Mar 2021
The focus may be on COVID vaccines, but anti-virals are also showing a lot of promise
@megtirrell reports on new tools to fight the virus:
8
25
86
8 Mar 2021
#AT527 PH1 result #croi2021 well-tolerated potential for meaningful uptake in lungs; suggest drug exposure in lungs above level needed to inhibit viral replication. AT-527 targets #SARSCoV2 RNA polymerase responsible for viral RNA replication/transcription
bit.ly/2OgqLDr